Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 20,999	$ 11,346	$ 39,317	$ 22,290
General and administrative	5,785	4,977	11,991	9,911
Total operating expenses	26,784	16,323	51,308	32,201
Loss from operations	(26,784)	(16,323)	(51,308)	(32,201)
Interest income	2,861	408	5,556	516
Interest expense	(385)	(272)	(755)	(526)
Net loss	$ (24,308)	$ (16,187)	$ (46,507)	$ (32,211)
Net loss per common share, Basic	$ (0.34)	$ (0.25)	$ (0.64)	$ (0.52)
Net loss per common share, Diluted	$ (0.34)	$ (0.25)	$ (0.64)	$ (0.52)
Weighted-average shares used to compute net loss per common share, Basic	72,461,850	64,279,634	72,395,410	62,465,092
Weighted-average shares used to compute net loss per common share, Diluted	72,461,850	64,279,634	72,395,410	62,465,092